Lipocine Ownership | Who Owns Lipocine?
Lipocine Ownership Summary
Lipocine is owned by 9.87% institutional investors, 2.91% insiders, and 87.22% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.67% of LPCN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.66% of its assets in Lipocine shares.
LPCN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lipocine | 9.87% | 2.91% | 87.22% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 89.27K | 1.67% | $282.10K |
| Caldwell sutter capital | 471.00 | 0.01% | $1.49K |
| Tidemark | 59.00 | 0.00% | $186.00 |
| Jpmorgan chase | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caldwell sutter capital | 471.00 | 0.00% | $1.49K |
| Tidemark | 59.00 | 0.00% | $186.00 |
| Jpmorgan chase | - | - | - |
| Blackrock funding, inc. /de | 89.27K | - | $282.10K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tidemark | 59.00 | 0.00% | - |
| Caldwell sutter capital | 471.00 | 0.00% | - |
| Blackrock funding, inc. /de | 89.27K | - | - |
| Jpmorgan chase | - | - | -11.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | - | - | -11.00 |
| Tidemark | 59.00 | 0.00% | - |
| Caldwell sutter capital | 471.00 | 0.00% | - |
| Blackrock funding, inc. /de | 89.27K | - | - |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 18 | -5.26% | 528,356 | 2.10% | 9 | 10.55% | 5 | -54.55% | 7 | 133.33% |
| Mar 31, 2025 | 19 | 11.76% | 517,473 | 6.33% | 9 | 11.64% | 11 | 120.00% | 3 | -25.00% |
| Dec 31, 2024 | 17 | -5.56% | 486,671 | -10.62% | 9 | 8.79% | 5 | -50.00% | 4 | - |
| Sep 30, 2024 | 18 | - | 544,524 | 2.43% | 10 | 10.29% | 10 | - | - | -100.00% |
| Jun 30, 2024 | 18 | 5.88% | 531,604 | 12.18% | 9 | 12.52% | 10 | 100.00% | 4 | -20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 142.77K | 2.66% | -3.12K |
| Vanguard US Total Market Shares ETF | 141.08K | 2.64% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 51.03K | 0.95% | -23.25K |
| Fidelity Extended Market Index | 29.59K | 0.55% | -77.00 |
| Vifag 2002 SICAV | 17.77K | 0.33% | - |
| BlackRock Extended Equity Market K | 12.86K | 0.24% | -5.00 |
| Extended Equity Market Fund K | 12.47K | 0.23% | -249.00 |
| Fidelity Total Market Index | 8.74K | 0.16% | - |
| Dimensional US Targeted Value ETF | 8.13K | 0.15% | - |
| Fidelity Series Total Market Index | 7.77K | 0.15% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 25, 2023 | Patel Mahesh V. | CEO and President | Buy | $43.79K |
| Mar 24, 2023 | Patel Mahesh V. | CEO and President | Buy | $48.00K |
| Mar 20, 2023 | Ono Richard Dana | - | Buy | $1.36K |
| Mar 17, 2023 | Patel Mahesh V. | CEO and President | Buy | $16.50K |
| Nov 22, 2022 | Papapetropoulos Spyros | - | Buy | $10.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
LPCN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools